These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9514905)

  • 41. Protein kinase C mediated anti-proliferative glucocorticoid-sphinganine synergism in cultured Pollard III prostate tumor cells.
    Sosnowski J; Stetter-Neel C; Cole D; Durham JP; Mawhinney MG
    J Urol; 1997 Jul; 158(1):269-74. PubMed ID: 9186373
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Signaling pathways in the induction of c-fos and c-jun proto-oncogenes by 3-methylcholanthrene.
    Ainbinder E; Bergelson S; Daniel V
    Recept Signal Transduct; 1997; 7(4):279-89. PubMed ID: 9633828
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oncogene-induced up-regulation of Caco-2 cell proliferation involves IGF-II gene activation through a protein kinase C-mediated pathway.
    Cadoret A; Baron-Delage S; Bertrand F; Kornprost M; Groyer A; Gespach C; Capeau J; Cherqui G
    Oncogene; 1998 Aug; 17(7):877-87. PubMed ID: 9780004
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regulator of G-protein signaling 2 (RGS2) inhibits androgen-independent activation of androgen receptor in prostate cancer cells.
    Cao X; Qin J; Xie Y; Khan O; Dowd F; Scofield M; Lin MF; Tu Y
    Oncogene; 2006 Jun; 25(26):3719-34. PubMed ID: 16449965
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The phosphatidylinositol 3'-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells.
    Lin J; Adam RM; Santiestevan E; Freeman MR
    Cancer Res; 1999 Jun; 59(12):2891-7. PubMed ID: 10383151
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Androgen regulation of the human ornithine decarboxylase promoter in prostate cancer cells.
    Bai G; Kasper S; Matusik RJ; Rennie PS; Moshier JA; Krongrad A
    J Androl; 1998; 19(2):127-35. PubMed ID: 9570735
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Growth control of human prostatic cancer cells by the phorbol ester TPA: possible involvement of protein kinases.
    Konno S; Hsieh TC; Wu JM; Chen Y; Chiao JW; Mallouh C
    Anticancer Res; 1996; 16(4A):1843-9. PubMed ID: 8712711
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phenotypic effects of overexpression of PKC beta 1 in rat liver epithelial cells.
    Hsieh LL; Hoshina S; Weinstein IB
    J Cell Biochem; 1989 Dec; 41(4):179-88. PubMed ID: 2533931
    [TBL] [Abstract][Full Text] [Related]  

  • 49. RB activation and repression of C-MYC transcription precede apoptosis of human prostate epithelial cells.
    Zhao X; Day ML
    Urology; 2001 May; 57(5):860-5. PubMed ID: 11337282
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protein kinase C is inhibited by bisphosphonates in prostate cancer PC-3 cells.
    Tatsuda Y; Iguchi K; Usui S; Suzui M; Hirano K
    Eur J Pharmacol; 2010 Feb; 627(1-3):348-53. PubMed ID: 19903468
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhanced c-fos expression after intracellular iron deprivation.
    Fukuchi K; Tomoyasu S; Watanabe K; Watanabe H; Takagi Y; Tsuruoka N; Gomi K
    Biochem Mol Biol Int; 1993 Jul; 30(3):403-9. PubMed ID: 8401297
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential EGF action on nuclear protooncogenes in human endometrial carcinoma RL95-2 cells.
    Sallot M; Ordener C; Lascombe I; Propper A; Adessi GL; Jouvenot M
    Anticancer Res; 1996; 16(1):401-6. PubMed ID: 8615644
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Androgen regulation of programmed death of normal and malignant prostatic cells.
    Isaacs JT; Lundmo PI; Berges R; Martikainen P; Kyprianou N; English HF
    J Androl; 1992; 13(6):457-64. PubMed ID: 1293127
    [TBL] [Abstract][Full Text] [Related]  

  • 54. JNK interacting protein 1 (JIP-1) protects LNCaP prostate cancer cells from growth arrest and apoptosis mediated by 12-0-tetradecanoylphorbol-13-acetate (TPA).
    Ikezoe T; Yang Y; Taguchi H; Koeffler HP
    Br J Cancer; 2004 May; 90(10):2017-24. PubMed ID: 15138488
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cloning and characterization of phorbol ester differentiation-resistant U937 cell variants.
    Kiley SC; Adams PD; Parker PJ
    Cell Growth Differ; 1997 Feb; 8(2):221-30. PubMed ID: 9040944
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protein kinase C-{alpha} mediates epidermal growth factor receptor transactivation in human prostate cancer cells.
    Stewart JR; O'Brian CA
    Mol Cancer Ther; 2005 May; 4(5):726-32. PubMed ID: 15897236
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Luteinizing hormone-releasing hormone agonists interfere with the stimulatory actions of epidermal growth factor in human prostatic cancer cell lines, LNCaP and DU 145.
    Moretti RM; Marelli MM; Dondi D; Poletti A; Martini L; Motta M; Limonta P
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3930-7. PubMed ID: 8923840
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phorbol ester inhibition of estrogen-induced uterine deoxyribonucleic acid synthesis.
    Kirkland JL; Murthy L; Thomazy V; Hyder SM; Stancel GM
    Biol Reprod; 1998 Mar; 58(3):778-85. PubMed ID: 9510966
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes in protein kinase C activities are correlated with the metaplastic transformation of Schwann cell precursors of avian embryos into melanocytes.
    Hess L; Chamberlin T; Ciment G
    J Neurosci Res; 1988; 21(2-4):101-6. PubMed ID: 3216414
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential effects of phorbol ester on signaling and gene expression in human leukemia cells.
    Hass R; Prudovsky I; Kruhøffer M
    Leuk Res; 1997 Jul; 21(7):589-94. PubMed ID: 9301678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.